Morbidity and mortality of reoperation for coronary artery bypass grafting: significance of atheromatous vein grafts.

Reoperation ('redo') for coronary artery disease shows a significant increase in morbidity and mortality compared to primary surgery. Some technical approaches have been advocated to decrease myocardial injury, presumably due to coronary artery embolization from atheromatous vein grafts. From 1984 to 1989, 321 'redo' operations were performed at the Montreal Heart Institute. Patients with patent and atherosclerotic vein grafts at preoperative coronary angiography (239 patients) were compared to those with normal or occluded grafts (82 patients). Perioperative myocardial infarction and death rates were 19% and 13%, respectively. They were particularly high among patients with three or more patent and atherosclerotic vein grafts at reoperation (32% and 29%, respectively). Among the 239 patients with patent atherosclerotic grafts, the results of three different surgical techniques were studied retrospectively. A first group of 66 patients had early ligation of patent atheromatous grafts before cardioplegia was administered by antegrade infusion during single aortic clamping for coronary anastomoses, and maintained for the confection of aortic anastomoses. In a second group of 35 patients, early ligation of diseased graft, antegrade cardioplegic delivery, and partial aortic cross clamping for aortic anastomoses of vein grafts was done. In the third group of 138 patients, venous grafts were not interrupted before antegrade cardioplegic infusion and partial aortic cross clamping for aortic anastomoses of vein grafts was used. No significant difference in hospital mortality or perioperative myocardial infarction rate was observed between the three groups of patients. Thus, the modified techniques so far recommended for repeat coronary artery bypass grafting, such as early ligation of patent atherosclerotic grafts, have failed to improve the early results of 'redo' operations.